Fig. 1From: Effect of Erythropoietin-stimulating agent on uremic neuropathy in hemodialysis patients: a single-center open-label prospective studyComparison of the clinical neuropathy pattern between diabetic and non-diabetic patients. DM diabetic patients, Non-DM non-diabetic patientsBack to article page